Acasă

Azvudine beats paxlovid in reducing COVID-19 deaths

Sanatate

By Vijay Kumar Malesu Reviewed by Lily Ramsey, LLM Jan 21 2025 A large-scale study reveals azvudine’s comparable efficacy to Paxlovid, fewer adverse effects, and potential antitumor benefits in patients with liver cancer. Study:  Real‐world effectiveness and safety of oral azvudine versus nirmatrelvir‒ritonavir (Paxlovid) in hospitalized patients with COVID-19: a multicenter, retrospective, cohort study . Image Credit: Cryptographer/Shutterstock.com In a recent study published in the Signal

Tag-uri: Coronavirus

Azvudine beats paxlovid in reducing COVID-19 deaths https://www.news-medical.net - 21.01.2025 13:21

din zilele anterioare

Azvudine beats paxlovid in reducing COVID-19 deaths https://www.news-medical.net - 21.01.2025 13:21
STIRILE OREI
IN FOCUS: ‘When I die, who’s going to look after you?’ – the pains of caring for adults with disabilities https://www.channelnewsasia.com/ - 06:00
IN FOCUS: ‘When I die, who’s going to look after you?’ – the pains of caring for adults with disabilities https://www.channelnewsasia.com - 06:00
IN FOCUS: ‘I only wish to live one second longer’ – the pains of parents of adults with disabilities https://www.channelnewsasia.com/ - 06:00
IN FOCUS: ‘I only wish to live one second longer’ – the pains of parents of adults with disabilities https://www.channelnewsasia.com - 06:00
Spanish PM urges EU to ‘rebel’ against Silicon Valley https://www.rt.com - 14:23
© Copyright 2017 Mediafax SA | Termeni și condiţii | About cookies | Confidentialitate

monitoruldestiri@mediafax.ro

Fotografiile folosite de monitoruldestiri.ro sunt proprietatea Mediafax. Este interzisă republicarea acestora în lipsa unui acord din partea Mediafax. Pentru a obține acest acord, vă rugăm să ne contactați.